The Democratic Republic of Congo’s Ebola outbreak has crossed a grim threshold: it is now the country’s deadliest recorded epidemic, even as medical options lag behind the virus’s spread.

The conservative framing is stark and numerical, describing a “fast-moving” outbreak that has become Congo’s worst, with more than 2,300 dead.¹ The liberal account reaches the same conclusion but places greater emphasis on the scale and mechanics of the crisis: government data put the death toll at 2,325, with 4,945 confirmed cases and 101 new infections reported in a single day.²

The outbreak has affected six of the DRC’s 26 provinces, with more than 3,400 cases recorded in Ituri, where it began. Uganda has also reported at least 20 cases, underscoring the risk of cross-border transmission. The epidemic’s speed is particularly alarming: the report calls it the fastest-growing outbreak in the known history of Ebola, while the UN warned that “Ebola is winning” and estimated that one person was dying every 30 minutes.²

The central difference between the perspectives is not the diagnosis but the emphasis. The conservative headline highlights a national catastrophe; the liberal report explains why it is worsening. The current outbreak involves the rare Bundibugyo strain, for which there are no approved vaccines or antiviral treatments. Médecins Sans Frontières specialist Thomas Parisch said, “Instead, we’re still seeing many cases detected very late, when treatment is less likely to succeed, with many identified only after they die in the community.”²

That combination—limited treatment, delayed detection and expanding transmission—turns a record death toll into a warning about the limits of outbreak response when patients are reached only after the disease has become advanced.